APA (7th ed.) Citation

T, Z., MS, F., A, B., X, M., CE, T., DA, H., . . . SL, H. (2025). Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 31(13), 1543. https://doi.org/10.1177/13524585251389797

Chicago Style (17th ed.) Citation

T, Ziemssen, et al. "Clinical Validation of a Novel in Vitro Diagnostic Neurofilament Light Chain Assay for the Prognostication of Disease Activity in People with Relapsing Multiple Sclerosis." Multiple Sclerosis (Houndmills, Basingstoke, England) 31, no. 13 (2025): 1543. https://doi.org/10.1177/13524585251389797.

MLA (9th ed.) Citation

T, Ziemssen, et al. "Clinical Validation of a Novel in Vitro Diagnostic Neurofilament Light Chain Assay for the Prognostication of Disease Activity in People with Relapsing Multiple Sclerosis." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 31, no. 13, 2025, p. 1543, https://doi.org/10.1177/13524585251389797.